Russian Journal of Genetics

, 47:1117 | Cite as

Genes expression of metalloproteinases (MMP-1, MMP-2, MMP-9, and MMP-12) associated with psoriasis

  • N. L. Starodubtseva
  • V. V. Sobolev
  • A. G. Soboleva
  • A. A. Nikolaev
  • S. A. Bruskin
Human Genetics

Abstract

Using real-time polymerase chain reaction (RT-PCR), we measured mRNA amounts of matrix metalloproteinases (MMPs): MMP-1, MMP-2, MMP-9, and MMP-12 genes in psoriatic lesions and unaffected skin of the same patients. We observed significant (about 15-fold) increase in the expression level of matrix metalloproteinase MMP-1 and MMP-12 genes associated with psoriasis. The results of our studies of MMP gene expression in cultured primary human keratinocytes treated with interleukin (IL)-17 have shown upregulation of MMP gene expression both in cultured keratinocytes and in psoriatic skin lesions. Therefore, upregulation of MMP genes in the skin affected by psoriasis could result from IL-17 effects on skin cells.

References

  1. 1.
    Feng, B.J., Sun, L.D., Soltani-Arabshahi, R., et al., Multiple Loci within the Major Histocompatibility Complex Confer Risk of Psoriasis, PLoS Genet., 2009, vol. 5, no. 8, e1000606.PubMedCrossRefGoogle Scholar
  2. 2.
    Zhang, X.J., Huang, W., Yang, S., et al., Psoriasis Genome-Wide Association Study Identifies Susceptibility Variants within LCE Gene Cluster at 1q21, Nat. Genet., 2009, vol. 41, no. 2, pp. 205–210.PubMedCrossRefGoogle Scholar
  3. 3.
    Nair, R.P., Duffin, K.C., Helms, C., et al., Genome-Wide Scan Reveals Association of Psoriasis with IL-23 and NF-KappaB Pathways, Nat. Genet., 2009, vol. 41, no. 2, pp. 199–204.PubMedCrossRefGoogle Scholar
  4. 4.
    Hollox, E.J., Huffmeier, U., Zeeuwen, P., et al., Psoriasis Is Associated with Increased Beta Defensin Genomic Copy Number, Nat. Genet., 2008, vol. 40, no. 2, pp. 23–25.PubMedCrossRefGoogle Scholar
  5. 5.
    Galimova, E.S., Akhmetova, V.L., and Khusnutdinova, E.K., Molecular Genetic Bases of Susceptibility to Psoriasis, Russ. J. Genet., 2008, vol. 44, no. 5, pp. 594–605.CrossRefGoogle Scholar
  6. 6.
    Chandran, V. and Raychaudhuri, S.P., Geoepidemiology and Environmental Factors of Psoriasis and Psoriatic Arthritis, J. Autoimmunity, 2010, vol. 34, pp. 314–321.CrossRefGoogle Scholar
  7. 7.
    Lowes, M.A., Lew, W., Krueger, J.G., et al., Current Concepts in the Immunopathogenesis of Psoriasis, Dermatol. Clin., 2004, vol. 22, no. 4, pp. 349–369.PubMedCrossRefGoogle Scholar
  8. 8.
    Hansson, G.K., Robertson, A.K., and Soederberg-Naucler, C., Inflammation and Atherosclerosis, Annu. Rev. Pathol., 2006, vol. 1, pp. 297–329.PubMedCrossRefGoogle Scholar
  9. 9.
    Jiang, W.Y., Chattedee, A.D., Raychaudhuri, S.P., et al., Mast Cell Density and IL-8 Expression in Nonlesional and Lesional Psoriatic Skin, Int. J. Dermatol., 2001, vol. 40, no. 11, pp. 699–703.PubMedCrossRefGoogle Scholar
  10. 10.
    Schoen, M.P. and Boehncke, W.H., Psoriasis, N. Engl. J. Med., 2005, vol. 352, no. 18, pp. 1899–1912.CrossRefGoogle Scholar
  11. 11.
    Piruzyan, E.S., Nikol’skaya, T.A., Abdeev, R.M., et al., Components of the AP-1 Transcription Factor as Candidate Genes, Participating in the Development of Psoriasis, Mol. Biol. (Moscow), 2007, vol. 41, pp. 1069–1080.Google Scholar
  12. 12.
    Piruzyan, E.S., Sobolev, V.V., Abdeev, R.M., et al., Study of Molecular Mechanisms of Pathogenesis of Immunomediated Inflammatory Diseases by Example of Psoriasis, Acta Naturae, 2009, no. 3, pp. 139–150.Google Scholar
  13. 13.
    Piruzyan, E.S., Ishkin, A.A., Nikol’skaya, T.A., et al., Comparative Analysis of Molecular Genetic Processes in the Pathogeneses of Psoriasis and Crohn’s Disease, Mol. Biol. (Moscow), 2009, no. 1, pp. 175–179.Google Scholar
  14. 14.
    Piruzian, E., Bruskin, S., Ishkin, A., et al., Integrated Network Analysis of Transcriptomic and Proteomic Data in Psoriasis, BMC Syst. Biol., 2010, vol. 4, pp. 2–24.CrossRefGoogle Scholar
  15. 15.
    Parks, W.C., Wilson, C.L., Lopes-Boado, Y.S., et al., Matrix Metalloproteinases Modulators of Inflammation and Innate Immunity, Nat. Rev. Immunol., 2004, vol. 4, pp. 617–629.PubMedCrossRefGoogle Scholar
  16. 16.
    Hijova, E., Matrix Metalloproteinases: Their Biological Function and Clinical Implications, Bratisl. Lek. Listy, 2005, vol. 106, no. 3, pp. 127–132.PubMedGoogle Scholar
  17. 17.
    Elkington, P.T., O’Kane, C.M., and Friedland, J.S., The Paradox of Matrix Metalloproteinases in Infectious Disease, Clin. Exp. Immunol., 2005, vol. 142, no. 1, pp. 12–20.PubMedCrossRefGoogle Scholar
  18. 18.
    Manicone, A.M. and McGuire, K., Matrix Metalloproteinases as Modulators of Inflammation, Semin. Cell Dev. Biol., 2008, vol. 19, no. 1, pp. 34–41.PubMedCrossRefGoogle Scholar
  19. 19.
    Dumin, J.A., Dickeson, S.K., Stricker, T.P., et al., Pro-Collagenase-1 (Matrix Metalloproteinase-1) Binds the Alpha(2)Beta(1) Integrin upon Release from Keratinocytes Migrating on Type I Collagen, J. Biol. Chem., 2001, vol. 276, no. 31, pp. 29368–29374.PubMedCrossRefGoogle Scholar
  20. 20.
    McQuibban, G.A., Gong, J.H., Tam, E.M., et al., Imflammation Dampened by Gelatinase Cleavage of Monocyte Chemoattractant Protein-3, Science, 2000, vol. 289, no. 5482, pp. 1202–1206.PubMedCrossRefGoogle Scholar
  21. 21.
    Zhang, K., McQuibban, G.A., Silva, C., et al., HIV-Induced Metalloproteinase Processing of the Chemokine Stromal Cell Derived Factor-1 Causes Neurodegeneration, Nat. Neurosci., 2003, vol. 6, no. 10, pp. 1064–1071.PubMedCrossRefGoogle Scholar
  22. 22.
    Patterson, M.L., Atkinson, S.J., Knauper, V., et al., Specific Collagenolysis by Gelatinase A, MMP-2, Is Determined by the Hemopexin Domain and not the Fibronectin-Like Domain, FEBS Lett., 2001, vol. 503, nos. 2–3, pp. 158–162.PubMedCrossRefGoogle Scholar
  23. 23.
    Murphy, G., McAlpine, C.G., Poll, C.T., et al., Purification and Characterization of a Bone Metalloproteinase That Degrades Gelatin and Types IV and V Collagen, Biochim. Biophys. Acta, 1985, vol. 831, no. 1, pp. 49–58.PubMedCrossRefGoogle Scholar
  24. 24.
    Ito, A., Mukaiyama, A., Itoh, Y., et al., Degradation of Interleukin 1beta by Matrix Metalloproteinases, J. Biol. Chem., 1996, vol. 271, no. 25, pp. 14657–14660.PubMedCrossRefGoogle Scholar
  25. 25.
    Yu, Q. and Stamenkovic, I., Cell Surface Localized Matrix Metalloproteinase-9 Proteolytically Activates TGF-Beta and Promotes Tumor Invasion and Angiogenesis, Genes Dev., 2000, vol. 14, no. 2, pp. 163–176.PubMedGoogle Scholar
  26. 26.
    Murphy, G. and Nagase, H., Progress in Matrix Metalloproteinase Research, Mol. Aspects Med., 2008, vol. 29, no. 5, pp. 290–308.PubMedCrossRefGoogle Scholar
  27. 27.
    Kerkela, E., Bohling, T., Herva, R., et al., Human Macrophage Metalloelastase (MMP-12) Expression Is Induced in Chondrocytes during Fetal Development and Malignant Transformation, Bone, 2001, vol. 29, no. 5, pp. 487–493.PubMedCrossRefGoogle Scholar
  28. 28.
    Hou, P., Troen, T., Ovejero, M.C., et al., Matrix Metalloproteinase-12 (MMP-12) in Osteoclasts: New Lesson on the Involvement of MMPs in Bone Resorption, Bone, 2004, vol. 34, no. 1, pp. 37–47.PubMedCrossRefGoogle Scholar
  29. 29.
    Suomela, S., Kariniemi, A.L., Snellman, E., et al., Metalloelastase (MMP-12) and 92-kDa Gelatinase (MMP-9) as Well as Their Inhibitors, TIMP-1 and -3, Are Expressed in Psoriatic Lesions, Exp. Dermatol., 2001, vol. 10, no. 3, pp. 175–183.PubMedCrossRefGoogle Scholar
  30. 30.
    Clark, I.M., Swingler, T.E., Sampieri, C.L., and Edwards, D.R., The Regulation of Matrix Metalloproteinases and Their Inhibitors, Int. J. Biochem. Cell Biol., 2008, vol. 40, nos. 6–7, pp. 1362–1378.PubMedCrossRefGoogle Scholar
  31. 31.
    He, C., Molecular Mechanism of Transcriptional Activation of Human Gelatinase B by Proximal Promoter, Cancer Lett., 1996, vol. 106, no. 2, pp. 185–191.PubMedCrossRefGoogle Scholar
  32. 32.
    Elliott, S.F., Coon, C.I., Hays, E., et al., Bcl-3 Is an Interleukin-1-Responsive Gene in Chondrocytes and Synovial Fibroblasts That Activates Transcription of the Matrix Metalloproteinase 1 Gene, Arthritis Rheum., 2002, vol. 46, pp. 3230–3239.PubMedCrossRefGoogle Scholar
  33. 33.
    Livak, K.J. and Schmittgen, T.D., Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, 2001, vol. 25, no. 4, pp. 402–408.PubMedCrossRefGoogle Scholar
  34. 34.
    Aljada, A., Ghanim, H., Mohanty, P., et al., Hydrocortisone Suppresses Intranuclear Activator-Protein-1 (AP-1) Binding Activity in Mononuclear Cells and Plasma Matrix Metalloproteinase 2 and 9 (MMP-2 and MMP-9), J. Clin. Endocrinol. Metab., 2001, vol. 12, pp. 5988–5991.CrossRefGoogle Scholar
  35. 35.
    Karmakar, S. Dhar, R., and Das, C., Inhibition of Cytotrophoblastic (JEG-3) Cell Invasion by Interleukin 12 Involves an Interferon Gamma-Mediated Pathway, J. Biol. Chem., 2004, vol. 279, no. 53, pp. 55297–55307.PubMedCrossRefGoogle Scholar
  36. 36.
    Bachmeier, B.E., Albini, A., Vene, R., et al., Cell Density-Dependent Regulation of Matrix Metalloproteinase and TIMP Expression in Differently Tumorigenic Breast Cancer Cell Lines, Exp. Cell Res., 2005, vol. 305, no. 1, pp. 83–98.PubMedCrossRefGoogle Scholar
  37. 37.
    Hasegawa Hitoki, Senga Takeshi, Ito Satoko, et al., A Role for AP-1 in Matrix Metalloproteinase Production and Invadopodia Formation of v-Crk-Transformed Cells, Exp. Cell Res., 2009, vol. 315, no. 8, pp. 1384–1392.PubMedCrossRefGoogle Scholar
  38. 38.
    Fanjul-Fernandez, M., Folgueras, A.R., Cabrera, S., and Lopez-Otin, C., Matrix Metalloproteinases: Evolution, Gene Regulation and Functional Analysis in Mouse Models, Biochim. Biophys. Acta, 2010, vol. 1803, no. 1, pp. 3–19.PubMedCrossRefGoogle Scholar
  39. 39.
    Singh, N.K., Quyen, D.V., Kundumani-Sridharan, V., et al., AP-1 (Fra-1/C-Jun)-Mediated Induction of Expression of Matrix Metalloproteinase-2 Is Required for 15S-Hydroxyeicosatetraenoic Acid-Induced Angiogenesis, J. Biol. Chem., 2010, vol. 285, no. 22, pp. 16830–16843.PubMedCrossRefGoogle Scholar
  40. 40.
    Ni, J., Waldman, A., and Khachigian, L.M., C-Jun Regulates Shear- and Injury-Inducible Egr-1 Expression, Vein Graft Stenosis after Autologous End-to-Side Transplantation in Rabbits, and Intimal Hyperplasia in Human Saphenous Veins, J. Biol. Chem., 2010, vol. 285, no. 6, pp. 4038–4048.PubMedCrossRefGoogle Scholar
  41. 41.
    Xie, T.X., Wei, D., Liu, M., et al., Stat3 Activation Regulates the Expression of Matrix Metalloproteinase-2 and Tumor Invasion and Metastasis, Oncogene, 2004, vol. 23, pp. 3550–3560.PubMedCrossRefGoogle Scholar
  42. 42.
    Baker, S.J., Rane, S.G., and Reddy, E.P., Hematopoietic Cytokine Receptor Signaling, Oncogene, 2007, vol. 26, no. 47, pp. 6724–6737.CrossRefGoogle Scholar
  43. 43.
    Bergman, M.R., Cheng, S., Honbo, N., et al., A Functional Activating Protein 1 (AP-1) Site Regulates Matrix Metalloproteinase 2 (MMP-2) Transcription by Cardiac Cells through Interactions with JunB-Fra1 and JunB-FosB Heterodimers, Biochem. J., 2003, vol. 369, pp. 485–496.PubMedCrossRefGoogle Scholar
  44. 44.
    Lee, J.G., Dahi, S., Mahimkar, R., et al., Intronic Regulation of Matrix Metalloproteinase-2 Revealed by in vivo Transcriptional Analysis in Ischemia, Proc. Natl. Acad. Sci. USA, 2005, vol. 102, pp. 16345–16350.PubMedCrossRefGoogle Scholar
  45. 45.
    Yan, C. and Boyd, D.D., Regulation of Matrix Metalloproteinase Gene Expression, J. Cell Physiol., 2007, vol. 211, pp. 19–26.PubMedCrossRefGoogle Scholar
  46. 46.
    Schreiber, M., Wang, Z.Q., Jochum, W., et al., Placental Vascularisation Requires the AP-1 Component Fra1, Development, 2000, vol. 127, no. 22, pp. 937–948.Google Scholar
  47. 47.
    Sobolev, V.V., Zolotarenko, A.D., Soboleva, A.G., et al., Effects of Expression of Transcriptional Factor AP-1 FOSL1 Gene on Psoriatic Process, Byull. Eksp. Biol. Med., 2010, vol. 150, pp. 564–567.Google Scholar
  48. 48.
    Sobolev, V.V., Zolotorenko, A.D., Soboleva, A.G., et al., Expression of the FOSL1 Gene in Psoriasis and Atherosclerosis, Russ. J. Genet., 2010, vol. 46, no. 1, pp. 104–110.CrossRefGoogle Scholar
  49. 49.
    Fanjul-Fernndez, M., Folgueras, A.R., Cabrera, S., et al., Matrix Metalloproteinases: Evolution, Gene Regulation and Functional Analysis in Mouse Models, Biochim. Biophys. Acta, 2010, vol. 1803, no. 1, pp. 3–19.CrossRefGoogle Scholar
  50. 50.
    Flisiak, I., Zaniewski, P., and Chodynicka, B., Plasma TGF-Beta1, TIMP-1, MMP-1 and IL-18 as a Combined Biomarker of Psoriasis Activity, Biomarkers, 2008, vol. 13, no. 5, pp. 549–556.PubMedCrossRefGoogle Scholar
  51. 51.
    Flisiak, I., Porebski, P., and Chodynicka, B., Effect of Psoriasis Activity on Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 in Plasma and Lesional Scales, Acta Dermatol. Venereol., 2006, vol. 86, no. 1, pp. 17–21.Google Scholar
  52. 52.
    Suomela, S., Kariniemi, A.L., Snellman, E., et al., Metalloelastase (MMP-12) and 92-kDa Gelatinase (MMP-9) as Well as Their Inhibitors, TIMP-1 and -3, Are Expressed in Psoriatic Lesions, Exp. Dermatol., 2001, vol. 10, no. 3, pp. 175–183.PubMedCrossRefGoogle Scholar

Copyright information

© Pleiades Publishing, Ltd. 2011

Authors and Affiliations

  • N. L. Starodubtseva
    • 1
  • V. V. Sobolev
    • 2
  • A. G. Soboleva
    • 2
  • A. A. Nikolaev
    • 2
  • S. A. Bruskin
    • 2
  1. 1.Moscow Institute of Physics and TechnologyMoscowRussia
  2. 2.Vavilov Institute of General GeneticsRussian Academy of SciencesMoscowRussia

Personalised recommendations